SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Citigroup Maintains Buy on Bio-Rad Laboratories, Raises Price Target to $525

Citigroup maintains Bio-Rad Laboratories (NYSE:BIO) with a Buy and raises the price target from $480 to $525.

Benzinga · 05/07/2020 16:39

Citigroup maintains Bio-Rad Laboratories (NYSE:BIO) with a Buy and raises the price target from $480 to $525.